Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02382627 · ClinicalTrials.gov registry record
Choroidal Thickness in Optic Neuropathy
A clinical trial, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- 2
- Enrollment target
NCT02382627: Clinical Trial study, sponsored by University of Colorado, Denver.
NCT02382627 is a clinical trial that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02382627 was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study plans to learn more about the thickness of the choroid in patients with optic neuropathy. The choroid is a layer of blood vessels that supplies oxygen and nourishment to the outer layers of the retina. Patients are being asked to be in this research study because they have optic neuropathy and are receiving care at the University of Colorado Hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2015-03 |
| Est. Completion | 2018-12 |
Why NCT02382627 stopped before completion
NCT02382627 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02382627 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02382627 about?
NCT02382627 is a clinical study titled "Choroidal Thickness in Optic Neuropathy". This study plans to learn more about the thickness of the choroid in patients with optic neuropathy. The choroid is a layer of blood vessels that supplies oxygen and nourishment to the outer layers of the retina. Patients are being asked to be in this research study because they have optic neuropath...
What is the current status of trial NCT02382627?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2015-03. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT02382627?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia